HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GMPs

This article was originally published in The Tan Sheet

Executive Summary

FDA returns proposed dietary supplement reg to OMB March 28, almost two months after proposal was withdrawn due to Bush Administration hold (1"The Tan Sheet" Jan. 29, p. 3). CFSAN Office of Nutritional Products, Labeling & Dietary Supplements Director Christine Lewis, PhD, recently told industry stakeholders long-awaited proposal will not deviate significantly from third-party certification program standards (2"The Tan Sheet" March 26, p. 5)

You may also be interested in...



Supplement GMP Proposed Rule Similar To Third-Party Programs - Lewis

FDA's proposed rule on dietary supplement Good Manufacturing Practices will not deviate significantly from the standards being established by newly-formed third-party certification programs, according to CFSAN Office of Nutritional Products, Labeling & Dietary Supplements Director Christine Lewis, PhD.

Dietary Supplement GMPs Stuck In Transition Limbo

FDA's proposed rule establishing dietary supplement Good Manufacturing Practices appears to be caught amid the flood of activity surrounding the transition to a new presidential Administration.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS132247

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel